Srinagar Magazine

Delveinsight Business Research LLP

Dementia is a syndrome characterized by a progressive cognitive deficit in multiple domains, behavioral and psychological symptoms (BPSD), which may ultimately lead to dependency on caregivers. Alzheimer disease (AD) and vascular dementia (VaD) is the most common dementia disorders that account for 60% and 20% of dementia cases, respectively.

Patients who express both AD and cerebrovascular pathology may receive a diagnosis of mixed dementia. Dementia with Lewy bodies (DLB) is considered to be the third most common, but conclusive evidence is still lacking. Less frequent dementia disorders include Parkinson’s disease dementia (PDD) and front temporal dementia (FTD).

Type 2 diabetes and dementia are prevalent in the elderly and have a considerable impact on public health and patient quality of life. Recent estimates suggest that 382 million and 44 million individuals worldwide are affected by type 2 diabetes and dementia, respectively.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/dementia-with-diabetes-market-forecast

The Dementia with Diabetes Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Dementia with Diabetes market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Dementia with Diabetes treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Dementia with Diabetes Market Key Facts

• According to the World Health Organization (WHO), dementia is recognized as a public health priority. In May 2017, the World Health Assembly endorsed the Global action plan on the public health response to dementia 2017–2025. The Plan provides a comprehensive blueprint for action – for policy-makers, international, regional, and national partners.

• As per the American Diabetes Association, the majority of studies focus on the prospective risk of dementia in patients with diabetes. However, there are 46 million people already living with dementia in 2015, and the estimated prevalence of diabetes in dementia patients is 13–20%.

• A study conducted by Ninomiya et al. titled “Epidemiological Evidence of the Relationship Between Diabetes And Dementia” stated that growing epidemiological evidence in subjects with diabetes mellitus is at an increased risk for the development of dementia. Diabetes mellitus is associated with a 1.5- to 2.5-fold greater risk of dementia among community-dwelling elderly people.

• Diabetes was associated with a ∼60% increased risk of all-cause dementia and a 40% risk of nonvascular dementia in both women and men, independent of important confounders. For vascular dementia, the association was stronger, with evidence of a stronger effect in women than in men. Course-modifying treatment and prevention strategies for diabetes-associated cognitive dysfunction, particularly mild cognitive impairment and dementia, remain the highest unmet needs.

Key Benefits of Dementia with Diabetes Market Report

• Dementia with Diabetes market report provides an in-depth analysis of Dementia with Diabetes Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

• The report will help in developing business strategies by understanding the Dementia with Diabetes Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

• The market report covers the Dementia with Diabetes current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

• The report provides a detailed assessment of the Dementia with Diabetes market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Dementia with Diabetes Market

The Dementia with Diabetes Market Size is expected to change due to the improvement in the diagnosis, incremental healthcare expenditure across the world, and anticipated launch of emerging therapies during the forecast period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Dementia with Diabetes market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Dementia with Diabetes Market Trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

Dementia with Diabetes Epidemiology

The epidemiology section covers insights about the historical and current Dementia with Diabetes patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Dementia with Diabetes Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Dementia with Diabetes Market or expected to get launched in the market during the study period. The analysis covers Dementia with Diabetes market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Dementia with Diabetes Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Dementia with Diabetes market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for Dementia with Diabetes emerging therapies.

There is no cure for Dementia with Diabetes; however, the current treatment option includes non-insulin therapy (Thiazolidinediones, Meglitinides and Dipeptidyl peptidase-4 inhibitors) and insulin therapy. The pipeline for Dementia with Diabetes illustrates a high medical unmet need; therefore, a better treatment option is required in the upcoming Years. Companies worldwide are persistently working toward the development of new treatment therapies, such as vTv Therapeutics LLC and others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Dementia with Diabetes Competitive Intelligence Analysis

4. Dementia with Diabetes Market Overview at a Glance

5. Dementia with Diabetes Disease Background and Overview

6. Dementia with Diabetes Patient Journey

7. Dementia with Diabetes Epidemiology and Patient Population

8. Dementia with Diabetes Treatment Algorithm, Current Treatment, and Medical Practices

9. Dementia with Diabetes Unmet Needs

10. Key Endpoints of Dementia with Diabetes Treatment

11. Dementia with Diabetes Marketed Products

12. Dementia with Diabetes Emerging Therapies

13. Dementia with Diabetes Seven Major Market Analysis

14. Attribute Analysis

15. Dementia with Diabetes Market Outlook (7 major markets)

16. Dementia with Diabetes Access and Reimbursement Overview

17. KOL Views on the Dementia with Diabetes Market.

18. Dementia with Diabetes Market Drivers

19. Dementia with Diabetes Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/dementia-with-diabetes-market-forecast

Latest Reports By DelveInsight
Dementia with Diabetes Pipeline Insights
Dementia with Diabetes Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across Dementia with Diabetes Market. 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/